NCT05714553 2025-07-18NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursNuCana plcPhase 1/2 Terminated19 enrolled
NCT02611024 2025-07-09Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsPharmaMarPhase 1/2 Completed316 enrolled
NCT05944237 2025-06-08HTL0039732 in Participants With Advanced Solid TumoursCancer Research UKPhase 1/2 Recruiting150 enrolled
NCT04104776 2025-05-15A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasNovartisPhase 1/2 Recruiting275 enrolled
NCT05500508 2024-12-24Oral AMXT 1501 Dicaprate in Combination With IV DFMOAminex Therapeutics, Inc.Phase 1/2 Terminated15 enrolled
NCT03393858 2024-02-07Combination of Immunotherapy and Hyperthermia in Advanced Malignant MesotheliomaCapital Medical UniversityPhase 1/2 Terminated10 enrolled
NCT01627795 2018-04-18Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma TreatmentOshadi Drug AdministrationPhase 1/2 Suspended17 enrolled